Contributions from the silent majority dominate dengue virus transmission
Open Access
- 1 May 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 14 (5), e1006965
- https://doi.org/10.1371/journal.ppat.1006965
Abstract
Despite estimates that, each year, as many as 300 million dengue virus (DENV) infections result in either no perceptible symptoms (asymptomatic) or symptoms that are sufficiently mild to go undetected by surveillance systems (inapparent), it has been assumed that these infections contribute little to onward transmission. However, recent blood-feeding experiments with Aedes aegypti mosquitoes showed that people with asymptomatic and pre-symptomatic DENV infections are capable of infecting mosquitoes. To place those findings into context, we used models of within-host viral dynamics and human demographic projections to (1) quantify the net infectiousness of individuals across the spectrum of DENV infection severity and (2) estimate the fraction of transmission attributable to people with different severities of disease. Our results indicate that net infectiousness of people with asymptomatic infections is 80% (median) that of people with apparent or inapparent symptomatic infections (95% credible interval (CI): 0-146%). Due to their numerical prominence in the infectious reservoir, clinically inapparent infections in total could account for 84% (CI: 82-86%) of DENV transmission. Of infections that ultimately result in any level of symptoms, we estimate that 24% (95% CI: 0-79%) of onward transmission results from mosquitoes biting individuals during the pre-symptomatic phase of their infection. Only 1% (95% CI: 0.8-1.1%) of DENV transmission is attributable to people with clinically detected infections after they have developed symptoms. These findings emphasize the need to (1) reorient current practices for outbreak response to adoption of pre-emptive strategies that account for contributions of undetected infections and (2) apply methodologies that account for undetected infections in surveillance programs, when assessing intervention impact, and when modeling mosquito-borne virus transmission.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (P01AI098670)
- Agence Nationale de la Recherche (ANR-10- LABX-62-IBEID)
- National Institutes of Health (R01-AI091980)
- National Science Foundation (RTG/DMS - 1246991)
- National Institutes of Health (5R01AI102939-03)
- European Union Seventh Framework Programme (FP7/2007/2011)
- City of Paris Emergence(s) program in Biomedical Research
This publication has 59 references indexed in Scilit:
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunityJournal of The Royal Society Interface, 2013
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study YearPLoS Neglected Tropical Diseases, 2013
- Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoesProceedings of the National Academy of Sciences of the United States of America, 2013
- Clinical and Virological Factors Influencing the Performance of a NS1 Antigen-Capture Assay and Potential Use as a Marker of Dengue Disease SeverityPLoS Neglected Tropical Diseases, 2011
- Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune StatusThe Journal of Infectious Diseases, 2011
- From Re-Emergence to Hyperendemicity: The Natural History of the Dengue Epidemic in BrazilPLoS Neglected Tropical Diseases, 2011
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese AdultsPLoS Neglected Tropical Diseases, 2010
- Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus TransmissionPLoS Neglected Tropical Diseases, 2010
- Factors that make an infectious disease outbreak controllableProceedings of the National Academy of Sciences of the United States of America, 2004
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000